Skip to main content
Pashmeen Lakhani on Muck Rack

Pashmeen Lakhani

As seen in: Taylor & Francis Online
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Pashmeen

Contact Pashmeen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Evaluating clazosentan sodium for the treatment of aneurysmal subarachnoid hemorrhage

|
By Nived Jayaraj Ranjini, Kamran A. Zahoor, Pashmeen Lakhani, Jose Suarez
| Taylor & Francis Online
ABSTRACT Introduction Delayed cerebral ischemia (DCI), often linked to cerebral vasospasm, is a major cause of death and disability after aneurysmal subarachnoid hemorrhage (aSAH). Nimodipine remains the only Food and Drug Administration (FDA)-approved drug for DCI prevention. Areas covered The authors review clazosentan, a selective endothelin-A receptor antagonist approved in Japan and South Korea.
Open in Who Shared Issue with article?
See all 1 articles